CEO
Brian Murphy
Employees
11
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.
Loading...
Open
5.55
Mkt cap
150M
Volume
418K
High
5.62
P/E Ratio
9.34
52-wk high
19.41
Low
4.32
Div yield
N/A
52-wk low
1.44
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.